8-KThe WireRoutine
Bylaw Amendment
Filed Apr 10, 2026 · 2mo ago · Accession 0001193125-26-151300
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Intellia Therapeutics, Inc.
- Ticker
- NTLA
- CIK
- 1652130
- Form type
- 8-K
- Filing date
- Apr 10, 2026
- Report date
- Apr 7, 2026
- Document
- d65395d8k.htm
- Size
- 279 KB